Φορτώνει......
Impact of WIN site inhibitor on the WDR5 interactome
The chromatin-associated protein WDR5 is a promising pharmacological target in cancer, with most drug discovery efforts directed against an arginine-binding cavity in WDR5 called the WIN site. Despite a clear expectation that WIN site inhibitors will alter the repertoire of WDR5 interaction partners...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Cell Rep |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2021
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7871196/ https://ncbi.nlm.nih.gov/pubmed/33472061 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.celrep.2020.108636 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|